What is the price-to-earnings ratio of ABIOMED?
The price-earnings ratio of ABIOMED is currently 13.05.
ABIOMED P/S 2024
ABIOMED P/S
13.05
ABIOMED Dividend yield
Ticker
ABMD
ISIN
US0036541003
WKN
873886
As of May 12, 2024, ABIOMED's P/S ratio stood at 13.05, a 0% change from the 0 P/S ratio recorded in the previous year.
The ABIOMED P/S history
ABIOMED Aktienanalyse
What does ABIOMED do?
Abiomed Inc. is one of the most innovative companies in the medical technology industry. It was founded in 1981 and is headquartered in Danvers, Massachusetts. The company specializes in the development, manufacturing, and marketing of medical devices aimed at saving or improving patients' lives. Abiomed started as a small company focused on implantation technology for cardiac arrhythmias. However, the company soon recognized the need to concentrate on providing solutions for cardiac intensive care. Today, Abiomed is a leader in the field of cardiopulmonary support systems and offers innovative devices to support the heart. Abiomed's business model revolves around leveraging its expertise in medical technology for cardiology interventions and intensive care and bringing innovative products to market. The company has industry experts and doctors on its team who contribute to the development and manufacturing of products. This highest level of professionalism is also reflected in the distribution channels Abiomed utilizes, with a focus on delivering its products to clinics specialized in critical medical interventions. Abiomed is divided into various business segments that concentrate on the medical devices the company offers. One of these segments is the Impella portfolio, which focuses on heart pumps for acute heart failure. These pumps are capable of supporting the heart during cardiological intervention by pumping blood into the heart while artificially ventilating it. The Impella portfolio is recognized as a standard in cardiac intensive care. Another important area for Abiomed is product development. The company heavily invests in researching and developing new products to meet the current demand in cardiology on the market. Abiomed is aware that rapid development of new products can provide a competitive advantage and, therefore, is an essential part of its business model. The technology offered by Abiomed is revolutionary and allows for the treatment of patients with acute heart failure, which was previously difficult or impossible. This is a significant milestone for the company and the healthcare industry in general. Abiomed is aware of its responsibility towards patients, doctors, and hospitals and is continuously working to develop innovative solutions for the healthcare industry. In summary, Abiomed Inc. is a leading company in the medical technology industry that focuses on cardiology intervention and intensive care. The company is innovative and offers products that can save and improve patients' lives. The Impella portfolio, specializing in acute heart failure, is an important part of its business model. Abiomed heavily invests in research and development to consistently provide innovative solutions to its customers. ABIOMED ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding ABIOMED's P/S Ratio
ABIOMED's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing ABIOMED's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating ABIOMED's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in ABIOMED’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about ABIOMED Stock
How has the price-earnings ratio of ABIOMED changed compared to last year?
The price-to-earnings ratio of ABIOMED has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of ABIOMED high compared to other companies?
Yes, the price-to-earnings ratio of ABIOMED is high compared to other companies.
How does an increase in the price-earnings ratio of ABIOMED affect the company?
An increase in the price-earnings ratio of ABIOMED would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of ABIOMED affect the company?
A decrease in the price-earnings ratio of ABIOMED would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of ABIOMED?
Some factors that influence the price-earnings ratio of ABIOMED are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does ABIOMED pay?
Over the past 12 months, ABIOMED paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ABIOMED is expected to pay a dividend of 0 USD.
What is the dividend yield of ABIOMED?
The current dividend yield of ABIOMED is .
When does ABIOMED pay dividends?
ABIOMED pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of ABIOMED?
ABIOMED paid dividends every year for the past 0 years.
What is the dividend of ABIOMED?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is ABIOMED located?
ABIOMED is assigned to the 'Health' sector.
Wann musste ich die Aktien von ABIOMED kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of ABIOMED from 5/12/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/12/2024.
When did ABIOMED pay the last dividend?
The last dividend was paid out on 5/12/2024.
What was the dividend of ABIOMED in the year 2023?
In the year 2023, ABIOMED distributed 0 USD as dividends.
In which currency does ABIOMED pay out the dividend?
The dividends of ABIOMED are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The ABIOMED stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von ABIOMED
Our stock analysis for ABIOMED Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ABIOMED Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
